Uptake of HIV testing in patients with a confirmed sexually transmitted infection [8]

Sexually Transmitted Infections

Volumn 78, Issue 5, 2002, Pages 389-390

  Day, Sara ^a   Lakhani, D ^a   Rodgers, C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE;

HIV INFECTIONS; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUALLY TRANSMITTED DISEASES;

EID: 0036799224     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.78.5.389     Document Type: Letter

References (6)

1. Prevalence of HIV in the United Kingdom. Report of the unlinked anonymous prevalence monitoring programme United Kingdom: data to the end 1998. London: PHLS, 1999.
2. Grosskurth.H, Mosha F, Todd.J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
3. PHLS. AIDS and HIV infection in the UK: monthly report. Communicable Disease Report 2000;10:No13.
4. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men associated with gonococcal urethritis and CD4 depletion. J Infect. Dis 1995;172:1469-74.
5. Ghys PD, Fransen K, Diallo MO, et al. The association between cervicovaginal HIV shedding, sexually transmitted disease and immunosuppression in female sex workers in Abidjon, Cote d'Ivoire. AIDS 1997;11:F85-93.
6. The national strategy for sexual health and HIV: London: Department of Health, 2001.